Controversy over cervical cancer vaccine spurs safety surveillance

Nat Med. 2007 Apr;13(4):392-3. doi: 10.1038/nm0407-392b. Epub 2007 Mar 28.
No abstract available

Publication types

  • News

MeSH terms

  • Female
  • Humans
  • Papillomavirus Vaccines*
  • Product Surveillance, Postmarketing*
  • Risk Assessment
  • United States
  • Uterine Cervical Neoplasms / prevention & control*
  • Uterine Cervical Neoplasms / virology

Substances

  • Papillomavirus Vaccines